Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
It has the longest safety record and the most supporting evidence
We will also explore how peptides can help
Resources: Pickart, L., Vasquez-Soltero, J
Kit Contents: 1x BPC-157 (5mg) + TB-500 (5mg) Blend Vial (Lyophilised powder) 1x Bacteriostatic Water (10ml) Vial Important Notice This product is supplied strictly for in vitro laboratory research purposes
Cagrilintide and tesamorelin have meaningful human data in other settings
NIH has released four new SBIR/STTR solicitations (first deadline for all solicitations is September 8, 2026): Parent SBIR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track SBIR awards Parent STTR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track STTR awards SBIR Phase IIB Strategic Breakthrough Award (Clinical Trial Optional) accepts Phase IIB Strategic Breakthrough SBIR awards (for Phase II awardees) SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Clinical Trial Optional) accepts CRP awards (for Phase II awardees) Updated summaries of the research interests, budget waiver topics, and award mechanisms supported by individual Institutes and Centers (ICs) are now housed on the Small Business Funding Considerations and Contacts webpage
US$ 25.09
US$ 26.10
US$ 27.97
US$ 23.64
US$ 26.45
US$ 24.45
US$ 22.39
US$ 28.32
